WINTON GROUP Ltd - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 138 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WINTON GROUP Ltd ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$378,728
-33.2%
8,235
-16.5%
0.03%
-34.0%
Q2 2023$566,597
-41.4%
9,859
-61.8%
0.05%
-20.3%
Q1 2023$967,013
+9.2%
25,787
-18.4%
0.06%
+1.7%
Q4 2022$885,936
+19.6%
31,618
+20.0%
0.06%
+20.8%
Q3 2022$741,000
-28.1%
26,353
-11.1%
0.05%
-12.7%
Q2 2022$1,031,000
+71.8%
29,641
+77.3%
0.06%
+77.4%
Q1 2022$600,000
-29.0%
16,721
-53.9%
0.03%
-39.2%
Q4 2021$845,000
-23.8%
36,295
-37.8%
0.05%
-17.7%
Q3 2021$1,109,000
+2.3%
58,326
+8.5%
0.06%
+6.9%
Q2 2021$1,084,000
+18.9%
53,752
+8.0%
0.06%
+11.5%
Q1 2021$912,000
-3.9%
49,766
+5.5%
0.05%
-24.6%
Q4 2020$949,000
-48.0%
47,185
-51.5%
0.07%
+16.9%
Q3 2020$1,824,000
-59.0%
97,255
-51.0%
0.06%
-48.7%
Q2 2020$4,454,000
+264.2%
198,320
+140.7%
0.12%
+259.4%
Q1 2020$1,223,000
-31.6%
82,402
-11.1%
0.03%
+28.0%
Q4 2019$1,788,000
+473.1%
92,678
+489.4%
0.02%
+525.0%
Q3 2019$312,000
+29.5%
15,724
+33.5%
0.00%
-20.0%
Q1 2019$241,00011,7810.01%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2021
NameSharesValueWeighting ↓
FRIESS ASSOCIATES LLC 97,760$3,401,0005.68%
Nantahala Capital Management 1,000,000$34,790,0001.74%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 341,294$11,874,0001.52%
Portolan Capital Management 274,889$9,563,0000.96%
Quantedge Capital Pte Ltd 121,500$4,227,0000.85%
SHAKER INVESTMENTS LLC/OH 37,117$1,291,0000.82%
GLOBEFLEX CAPITAL L P 72,253$2,514,0000.61%
EAM Investors, LLC 68,855$2,395,0000.58%
Hillsdale Investment Management Inc. 197,738$6,879,0000.55%
Capital Impact Advisors, LLC 13,835$481,0000.44%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders